Related references
Note: Only part of the references are listed.β-amyloid redirects norepinephrine signaling to activate the pathogenic GSK3β/tau cascade
Fang Zhang et al.
SCIENCE TRANSLATIONAL MEDICINE (2020)
The Involvement of NLRP3 on the Effects of Minocycline in an AD-Like Pathology Induced by -Amyloid Oligomers Administered to Mice
Michelle Lima Garcez et al.
MOLECULAR NEUROBIOLOGY (2019)
The TDMQ Regulators of Copper Homeostasis Do Not Disturb the Activities of Cu,Zn-SOD, Tyrosinase, or the CoIII Cofactor Vitamin B12
Ju Huang et al.
EUROPEAN JOURNAL OF INORGANIC CHEMISTRY (2019)
Metal Ions in Alzheimer's Disease: A Key Role or Not?
Yan Liu et al.
ACCOUNTS OF CHEMICAL RESEARCH (2019)
Sodium oligomannate therapeutically remodels gut microbiota and suppresses gut bacterial amino acids-shaped neuroinflammation to inhibit Alzheimer's disease progression
Xinyi Wang et al.
CELL RESEARCH (2019)
Why Is Tetradentate Coordination Essential for Potential Copper Homeostasis Regulators in Alzheimer's Disease?
Youzhi Li et al.
EUROPEAN JOURNAL OF INORGANIC CHEMISTRY (2019)
N4-Tetradentate Chelators Efficiently Regulate Copper Homeostasis and Prevent ROS Production Induced by Copper-Amyloid-β1-16
Weixin Zhang et al.
CHEMISTRY-A EUROPEAN JOURNAL (2018)
Preparation of Tetradentate Copper Chelators as Potential Anti-Alzheimer Agents
Weixin Zhang et al.
CHEMMEDCHEM (2018)
Depression- and anxiety-like behaviour is related to BDNF/TrkB signalling in a mouse model of psoriasis
W. JiaWen et al.
CLINICAL AND EXPERIMENTAL DERMATOLOGY (2018)
Synthesis and characterization of copper-specific tetradendate ligands as potential treatment for Alzheimer's disease
Weixin Zhang et al.
COMPTES RENDUS CHIMIE (2018)
Metals and Alzheimer's Disease: How Far Have We Come in the Clinic?
Paul A. Adlard et al.
JOURNAL OF ALZHEIMERS DISEASE (2018)
Se-Methylselenocysteine Ameliorates Neuropathology and Cognitive Deficits by Attenuating Oxidative Stress and Metal Dyshomeostasis in Alzheimer Model Mice
Yongli Xie et al.
MOLECULAR NUTRITION & FOOD RESEARCH (2018)
Structures of the Copper and Zinc Complexes of PBT2, a Chelating Agent Evaluated as Potential Drug for Neurodegenerative Diseases
Michel Nguyen et al.
EUROPEAN JOURNAL OF INORGANIC CHEMISTRY (2017)
Pathology and hippocampal atrophy in Alzheimer's disease
Glenda Halliday
LANCET NEUROLOGY (2017)
Modulation of neuroinflammation and pathology in the 5XFAD mouse model of Alzheimer's disease using a biased and selective beta-1 adrenergic receptor partial agonist
Pooneh Memar Ardestani et al.
NEUROPHARMACOLOGY (2017)
Assessment of lipid peroxidation by measuring malondialdehyde (MDA) and relatives in biological samples: Analytical and biological challenges
Dimitrios Tsikas
ANALYTICAL BIOCHEMISTRY (2017)
Early effects of Aβ1-42 oligomers injection in mice: Involvement of PI3K/Akt/GSK3 and MAPK/ERK1/2 pathways
Fabiana Morroni et al.
BEHAVIOURAL BRAIN RESEARCH (2016)
The amyloid hypothesis of Alzheimer's disease at 25years
Dennis J. Selkoe et al.
EMBO MOLECULAR MEDICINE (2016)
Assessment of disease-related cognitive impairments using the novel object recognition (NOR) task in rodents
Ben Grayson et al.
BEHAVIOURAL BRAIN RESEARCH (2015)
Aβ induces oxidative stress in senescence-accelerated (SAMP8) mice
Kurara Takagane et al.
BIOSCIENCE BIOTECHNOLOGY AND BIOCHEMISTRY (2015)
Transfer of Copper from an Amyloid to a Natural Copper-Carrier Peptide with a Specific Mediating Ligand
Michel Nguyen et al.
CHEMISTRY-A EUROPEAN JOURNAL (2015)
The Necessity of Having a Tetradentate Ligand to Extract Copper(II) Ions from Amyloids
Michel Nguyen et al.
CHEMISTRYOPEN (2015)
Dual-functional nanoparticles targeting amyloid plaques in the brains of Alzheimer's disease mice
Chi Zhang et al.
BIOMATERIALS (2014)
Characterization of New Specific Copper Chelators as Potential Drugs for the Treatment of Alzheimer's Disease
Michel Nguyen et al.
CHEMISTRY-A EUROPEAN JOURNAL (2014)
Behavioral and EEG changes in male 5xFAD mice
F. Schneider et al.
PHYSIOLOGY & BEHAVIOR (2014)
Alzheimer's disease drug-development pipeline: few candidates, frequent failures
Jeffrey L. Cummings et al.
ALZHEIMERS RESEARCH & THERAPY (2014)
Comprehensive behavioral characterization of an APP/PS-1 double knock-in mouse model of Alzheimer's disease
Scott J. Webster et al.
ALZHEIMERS RESEARCH & THERAPY (2013)
Motor deficits, neuron loss, and reduced anxiety coinciding with axonal degeneration and intraneuronal A beta aggregation in the 5XFAD mouse model of Alzheimer's disease
Sadim Jawhar et al.
NEUROBIOLOGY OF AGING (2012)
Copper Chelator Induced Efficient Episodic Memory Recovery in a Non-Transgenic Alzheimer's Mouse Model
Johnatan Ceccom et al.
PLOS ONE (2012)
Adult hippocampal neurogenesis and its role in Alzheimer's disease
Yangling Mu et al.
MOLECULAR NEURODEGENERATION (2011)
A Mouse Model of Amyloid β Oligomers: Their Contribution to Synaptic Alteration, Abnormal Tau Phosphorylation, Glial Activation, and Neuronal Loss In Vivo
Takami Tomiyama et al.
JOURNAL OF NEUROSCIENCE (2010)
Icariin Improves Memory Impairment in Alzheimer's Disease Model Mice (5xFAD) and Attenuates Amyloid β-induced Neurite Atrophy
Takuya Urano et al.
PHYTOTHERAPY RESEARCH (2010)
The use of the elevated plus maze as an assay of anxiety-related behavior in rodents
Alicia A. Walf et al.
NATURE PROTOCOLS (2007)
Intraneuronal β-amyloid aggregates, neurodegeneration, and neuron loss in transgenic mice with five familial Alzheimer's disease mutations:: Potential factors in amyloid plaque formation
Holly Oakley et al.
JOURNAL OF NEUROSCIENCE (2006)
BACE1 deficiency rescues memory deficits and cholinergic dysfunction in a mouse model of Alzheimer's disease
M Ohno et al.
NEURON (2004)
Factors controlling measures of anxiety and responses to novelty in the mouse
SE File
BEHAVIOURAL BRAIN RESEARCH (2001)
Share Paper
